Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:27 pm Purchase | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | BIOTECHNOLOGY VALUE FUND L P | 768,200 9.990% | 427,540 (+125.50%) | Filing History |
| 2026-02-17 4:26 pm Purchase | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Point72 Asset Management, L.P. | 423,415 6.800% | 83,782 (+24.67%) | Filing History |
| 2026-02-17 4:08 pm Unchanged | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Lind Global Fund II LP | 442,480 6.620% | 0 (Unchanged) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Perceptive Advisors LLC | 569,308 9.100% | 130,166 (+29.64%) | Filing History |
| 2026-02-17 09:55 am Purchase | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Dellora Investments Master Fund LP | 401,071 6.400% | 50,000 (+14.24%) | Filing History |
| 2026-02-17 08:51 am Purchase | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | RTW Investments, LP | 650,968 9.900% | 232,528 (+55.57%) | Filing History |
| 2026-02-12 1:21 pm Purchase | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Morgan Stanley MS | 596,376 9.600% | 596,376 (New Position) | Filing History |
| 2025-12-23 4:30 pm Purchase | 2025-12-18 | 13G | TENAX THERAPEUTICS INC PAR TENX | Perceptive Advisors LLC | 439,142 7.000% | 439,142 (New Position) | Filing History |
| 2025-12-08 11:46 am Purchase | 2025-11-28 | 13G | TENAX THERAPEUTICS INC PAR TENX | Janus Henderson Group plc JHG | 623,733 9.990% | 457,067 (+274.24%) | Filing History |
| 2025-12-05 4:51 pm Unchanged | 2025-11-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Ikarian Capital, LLC | 967,600 15.500% | 0 (Unchanged) | Filing History |
| 2025-11-14 5:38 pm Purchase | 2025-09-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Venrock Healthcare Capital Partners III, L.P. | 552,970 9.900% | 103,478 (+23.02%) | Filing History |
| 2025-11-14 4:10 pm Purchase | 2025-09-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Lind Global Fund II LP | 442,480 8.800% | 67,480 (+17.99%) | Filing History |
| 2025-11-14 4:07 pm Purchase | 2024-09-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Vestal Point Capital, LP | 2,470,096 9.900% | 2,470,096 (New Position) | Filing History |
| 2025-11-05 4:24 pm Purchase | 2025-09-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Integrated Core Strategies (US) LLC | 313,712 6.900% | 80,096 (+34.29%) | Filing History |
| 2025-10-29 5:29 pm Purchase | 2025-10-22 | 13G | TENAX THERAPEUTICS INC PAR TENX | Point72 Asset Management, L.P. | 339,633 7.400% | 339,633 (New Position) | Filing History |
| 2025-10-07 4:15 pm Purchase | 2025-09-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Ikarian Capital, LLC | 967,600 21.200% | 967,600 (New Position) | Filing History |
| 2025-10-02 5:04 pm Purchase | 2025-09-26 | 13G | TENAX THERAPEUTICS INC PAR TENX | Invus Public Equities, L.P. | 427,141 9.400% | 427,141 (New Position) | Filing History |
| 2025-08-14 5:55 pm Sale | 2025-06-30 | 13G | CIDARA THERAPEUTICS INC NE CDTX | Venrock Healthcare Capital Partners III, L.P. | 449,492 9.900% | -649,504 (-59.10%) | Filing History |
| 2025-08-14 10:47 am Sale | 2025-06-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | Janus Henderson Group plc JHG | 166,666 4.000% | -229,976 (-57.98%) | Filing History |
| 2025-06-30 4:34 pm Purchase | 2025-06-26 | 13G | TENAX THERAPEUTICS INC PAR TENX | Integrated Core Strategies (US) LLC | 233,616 5.600% | 233,616 (New Position) | Filing History |